Privium Fund Management (UK)’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,103
| Closed | -$69.4K | – | 133 |
|
|
2024
Q2 | $69.4K | Sell |
12,103
-3,722
| -24% | -$21.3K | 0.03% | 155 |
|
|
2024
Q1 | $127K | Hold |
15,825
| – | – | 0.06% | 82 |
|
|
2023
Q4 | $92.3K | Hold |
15,825
| – | – | 0.06% | 72 |
|
|
2023
Q3 | $41.5K | Hold |
15,825
| – | – | 0.03% | 74 |
|
|
2023
Q2 | $40K | Hold |
15,825
| – | – | 0.03% | 69 |
|
|
2023
Q1 | $41K | Hold |
15,825
| – | – | 0.03% | 65 |
|
|
2022
Q4 | $24.5K | Hold |
15,825
| – | – | 0.02% | 53 |
|
|
2022
Q3 | $48K | Buy |
+15,825
| New | +$48K | 0.06% | 54 |
|